Global Cardiac Mapping Market Growth Rate 2024, Forecast To 2033
22 Aug, 2024
The cardiac mapping market size has seen significant growth recently, expanding from $2.15 billion in 2023 to $2.30 billion in 2024, reflecting a CAGR of 7.3%. This historic growth is due to the introduction of catheter ablation, advancements in 3D mapping systems, improvements in imaging technologies, an increase in the prevalence of cardiac arrhythmias, and growth in minimally invasive procedures. Looking forward, the market is projected to reach $3.06 billion in 2028 at a CAGR of 7.4%, driven by the increasing prevalence of cardiovascular diseases, a growing aging population, rising awareness and screening programs, enhanced healthcare infrastructure, and a higher prevalence of health issues. Key trends in the forecast period include AI integration, real-time 3D mapping systems, improved catheter technologies, cloud-based data analysis, and enhanced electrophysiology software.
Global Cardiac Mapping Market Key Driver
The prevalence of heart ailments is expected to accelerate the growth of the cardiac mapping market. Heart ailments, including arrhythmias, heart attacks, and heart failure, are influenced by sedentary lifestyles, poor dietary habits, and aging populations. Cardiac mapping aids in diagnosing and treating these conditions by identifying electrical abnormalities in the heart’s rhythm. For instance, the British Heart Foundation reported in January 2024 that over one million individuals in the UK suffer from heart failure, with approximately 200,000 new cases diagnosed annually and about 730,000 people listed on their GP's heart failure register. This rising prevalence of heart ailments is driving the expansion of the cardiac mapping market.
Get A Free Sample Of The Cardiac Mapping Market ReportGlobal Cardiac Mapping Market Segments
The cardiac mapping market covered in this report is segmented –
1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems
2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
By Geography:The regions covered in the cardiac mapping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the cardiac mapping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
Major Cardiac Mapping Industry Players
Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies, Boston Scientific Corporation, Epmap-System, APN Health LLC, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Biosense Webster Inc., BioSig Technologies Inc., CardioFocus Inc., Kardium Inc., Acutus Medical Inc., Navix Medical Ltd., EP Solutions SA, CoreMap Inc., Catheter Precision Inc.
Purchase The Global Cardiac Mapping Market Report Directly And Get A Swift DeliveryCardiac Mapping Market Overview
Cardiac mapping refers to the process of creating a detailed representation of the electrical activity within the heart. It helps identify abnormal heart rhythms (arrhythmias) by mapping the location and patterns of electrical impulses. This information is crucial for diagnosing and treating various cardiac conditions and guiding procedures such as ablation therapy to correct irregular heartbeats.
Cardiac Mapping Global Market Report 2023 provides data on the global cardiac mapping market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cardiac mapping market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.